Prostate Cancer - Results from #1040

Detecting androgen receptor (AR), AR variant 7 (AR-V7), prostate-specific membrane antigen (PSMA), and prostate-specific antigen (PSA) gene expression in CTCs and plasma exosome-derived cfRNA in patients with metastatic castration-resistant prostate cance April 18, 2024

Outcomes of 10 years of PSA screening for prostate cancer in Norwegian men with Lynch syndrome. April 18, 2024

Management of advanced prostate cancer in the Asia-Pacific region: Summary of the Asia-Pacific Advanced Prostate Cancer Consensus Conference 2023. April 18, 2024

Timing of treatment shapes the path to androgen receptor signaling inhibitor resistance in prostate cancer. April 18, 2024

Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancer. April 18, 2024

Redirecting the pioneering function of FOXA1 with covalent small molecules. April 18, 2024

ERG activates a stem-like proliferation-differentiation program in prostate epithelial cells with mixed basal-luminal identity. April 18, 2024

MRI-Ultrasound Fused Approach for Prostate Biopsy-How It Is Performed. April 17, 2024

Astragaloside IV-PESV inhibits prostate cancer tumor growth by restoring gut microbiota and microbial metabolic homeostasis via the AGE-RAGE pathway. April 17, 2024

A Comprehensive Overview of Intraoperative Complications during Retzius-Sparing Robot-Assisted Radical Prostatectomy: Single Series from High-Volume Center. April 17, 2024

Development and validation of a deep learning-based microsatellite instability predictor from prostate cancer whole-slide images. April 17, 2024

Distinct Prostate Cancer Survival Outcomes in Firefighters: A Population-Based Study. April 17, 2024

Long term evaluation of optimized Gleason grading in a large cohort of men with prostate cancer in Canada. April 17, 2024

Supported exercise TrAining for Men wIth prostate caNcer on Androgen deprivation therapy (STAMINA): study protocol for a randomised controlled trial of the clinical and cost-effectiveness of the STAMINA lifestyle intervention compared with optimised usual April 16, 2024

Patient Reported Sexual Adaptation Following Prostate Cancer Treatment: An Analysis of Related Variables and Sexual Outcomes Associated with Sexual Adaptation Styles. April 16, 2024

Biomarkers for Pre-Treatment Risk Stratification of Prostate Cancer Patients: A Systematic Review. April 16, 2024

Precision medicine for prostate cancer: An international perspective. April 16, 2024

Salvage Androgen Deprivation Therapy as Potential Treatment for Recurrence after Robot-Assisted Radical Prostatectomy. April 16, 2024

Prognostic Significance of the Cribriform Pattern in Prostate Cancer: Clinical Outcomes and Genomic Alterations. April 16, 2024

[177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial. April 16, 2024

Page 53 of 1436